Drug Eluting Balloon Versus Drug Eluting Stent in PCI

Launched by AZIENDA OSPEDALIERO UNIVERSITARIA MAGGIORE DELLA CARITA · Jan 2, 2013

Keywords

ClinConnect Summary

Drug eluting balloons (DEB) have been developed to overcome the limitations of drug eluting stent (DES), but clinical results of different studies about DEB are not consistent. Thus, we performed a meta-analysis to compare outcomes of DEB and DES in coronary artery disease (CAD).

The meta-analysis was performed according to the recommended methods \[14-15\]. A systematic search for eligible studies involved MEDLINE, CENTRAL, Embase, Highwire Press, Scopus and Google Scholar databases and was conducted without language restriction by two independent investigators (A.L. and A.R.), using the ...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • randomized studies or cohort studies reporting a comparison between a DEB treated group and a DES treated group
• • availability of reports of late lumen loss (LLL) and/or overall death and/or myocardial infarction (MI) and/or stent thrombosis (ST) and/or target lesion revascularization (TLR).
• Exclusion Criteria:
• • duplicate reporting (in which case the manuscript reporting the largest sample or the longest follow-up was selected)
• • follow up of at least 1 year
• • studies presenting composite major adverse cardiac events (MACE) without mentioning individual end points.